Rheumatology International

, Volume 35, Issue 2, pp 337–344 | Cite as

Mitochondrial DNA haplogroups modulate the radiographic progression of Spanish patients with osteoarthritis

  • Angel Soto-Hermida
  • Mercedes Fernández-Moreno
  • Sonia Pértega-Díaz
  • Natividad Oreiro
  • Carlos Fernández-López
  • Francisco J. BlancoEmail author
  • Ignacio Rego-PérezEmail author
Original Article


Not all patients with osteoarthritis (OA) show the same disease progression, as some of them remain relatively stable over time, while others progress to severe structural deterioration of the joint. In this sense, the main goal of both genetic and protein biomarkers in OA is to predict not only the risk of OA at an earlier stage of the disease but also which OA patients are more likely to progress to severe disease. Taking into account the incidence of the mitochondria and the mtDNA haplogroups in the pathogenesis of OA, the main objective of this work was to evaluate the incidence of the mtDNA haplogroups in the radiographic progression of the OA disease in a well-characterized follow-up cohort of Spanish patients. DNA from 281 OA patients from Hospital Universitario A Coruña was isolated to determine the European mtDNA haplogroups. Knee or hip radiographs from all affected joints were obtained at two time points with at least 36 months apart. Radiographs were evaluated using the Kellgren/Lawrence (K/L) scale; radiographic OA progression was defined as any radiographic worsening of the K/L joint score. Statistical analyses included Kaplan–Meier survival curves and Cox regression models. Patients belonging to the cluster TJ showed a slower radiographic OA progression than patients in the cluster KU (p = 0.036). Moreover, patients carrying the most common mtDNA haplogroup H are more apt to require total joint replacement surgery than non-H patients (p = 0.049). The inherited mitochondrial variants influence the radiographic progression of OA and could be considered among the genetic variants taken into account when the radiographic progression of OA is analyzed.


Mitochondria Haplogroups Osteoarthritis Cartilage Progression K/L grade 



Applied biosystems


American college of Rheumatology


Adenosine triphosphate


Body mass index


Confidence interval


Cartilage intermediate layer protein


Deoxyribonucleic acid


Growth differentiation factor 5


Hazard ratio


Interleukin-1 receptor antagonist


Joint space width


Kellgren and Lawrence


Mitochondrial respiratory chain


Mitochondrial deoxyribonucleic acid




Osteoarthritis initiative


Odds ratio


Oxidative phosphorylation system


Polymerase chain reaction


Restriction fragment length polymorphism


Reactive oxygen species


Single base extension


Single nucleotide polymorphism


Statistical package for the social sciences



The authors express appreciation to Lourdes Sanjurjo and Maria Dolores Velo and to the Department of Orthopaedic Surgery from the CHU A Coruña. This study was supported by grants from Fundación Española de Reumatologia (programa GEN-SER) and from Fondo Investigación Sanitaria (CIBER- CB06/01/0040)-Spain, Fondo Investigacion Sanitaria-PI 12/329 Ministerio Ciencia en Innovacion PLE2009-0144, with participation of funds from FEDER (European Community). Ignacio Rego-perez was supported by Contrato Miguel Servet-Fondo Investigacion Sanitaria (CP12/03192).

Conflict of interest

The authors declare that they have no conflict interest.


  1. 1.
    Felson DT, Zhang Y (1998) An update on the epidemiology of knee and hip osteoarthritis with a view to prevention. Arthritis Rheum 41(8):1343–1355PubMedCrossRefGoogle Scholar
  2. 2.
    Valdes AM, Spector TD (2011) Genetic epidemiology of hip and knee osteoarthritis. Nat Rev Rheumatol 7(1):23–32Google Scholar
  3. 3.
    Blanco FJ, Rego I, Ruiz-Romero C (2011) The role of mitochondria in osteoarthritis. Nat Rev Rheumatol 7(3):161–169PubMedCrossRefGoogle Scholar
  4. 4.
    Maneiro E, Martin MA, de Andres MC et al (2003) Mitochondrial respiratory activity is altered in osteoarthritic human articular chondrocytes. Arthritis Rheum 48(3):700–708PubMedCrossRefGoogle Scholar
  5. 5.
    Kim HA, Blanco FJ (2007) Cell death and apoptosis in osteoarthritic cartilage. Curr Drug Targets 8(2):333–345PubMedCrossRefGoogle Scholar
  6. 6.
    Cillero-Pastor B, Carames B, Lires-Dean M, Vaamonde-Garcia C, Blanco FJ, Lopez-Armada MJ (2008) Mitochondrial dysfunction activates cyclooxygenase 2 expression in cultured normal human chondrocytes. Arthritis Rheum 58(8):2409–2419PubMedCrossRefGoogle Scholar
  7. 7.
    Blanco FJ, Lopez-Armada MJ, Maneiro E (2004) Mitochondrial dysfunction in osteoarthritis. Mitochondrion 4(5–6):715–728Google Scholar
  8. 8.
    Henrotin Y, Kurz B (2007) Antioxidant to treat osteoarthritis: dream or reality? Curr Drug Targets 8(2):347–357PubMedCrossRefGoogle Scholar
  9. 9.
    Grishko VI, Ho R, Wilson GL, Pearsall AW (2009) Diminished mitochondrial DNA integrity and repair capacity in OA chondrocytes. Osteoarthritis Cartilage 17(1):107–113PubMedCentralPubMedCrossRefGoogle Scholar
  10. 10.
    Torroni A, Huoponen K, Francalacci P et al (1996) Classification of European mtDNAs from an analysis of three European populations. Genetics 144(4):1835–1850PubMedCentralPubMedGoogle Scholar
  11. 11.
    Rego-Perez I, Fernandez-Moreno M, Fernandez-Lopez C, Arenas J, Blanco FJ (2008) Mitochondrial DNA haplogroups: role in the prevalence and severity of knee osteoarthritis. Arthritis Rheum 58(8):2387–2396PubMedCrossRefGoogle Scholar
  12. 12.
    Rego I, Fernández-Moreno M, Fernández-López C et al (2010) Role of European mitochondrial DNA haplogroups in the prevalence of hip osteoarthritis in Galicia, Northern Spain. Ann Rheum Dis 69(1):210–213PubMedCrossRefGoogle Scholar
  13. 13.
    Soto-Hermida A, Fernandez-Moreno M, Oreiro N, Fernandez-Lopez C, Rego-Perez I, Blanco FJ (2014) mtDNA haplogroups and osteoarthritis in different geographic populations. Mitochondrion 15:18–23Google Scholar
  14. 14.
    Fang H, Liu X, Shen L et al (2014) Role of mtDNA haplogroups in the prevalence of knee osteoarthritis in a southern Chinese population. Int J Mol Sci 15(2):2646–2659PubMedCentralPubMedCrossRefGoogle Scholar
  15. 15.
    Rego-Pérez I, Fernández-Moreno M, Deberg M et al (2010) Mitochondrial DNA haplogroups modulate the serum levels of biomarkers in patients with osteoarthritis. Ann Rheum Dis 69(5):910–917PubMedCrossRefGoogle Scholar
  16. 16.
    Rego-Perez I, Fernandez-Moreno M, Deberg M et al (2011) Mitochondrial DNA haplogroups and serum levels of proteolytic enzymes in patients with osteoarthritis. Ann Rheum Dis 70(4):646–652Google Scholar
  17. 17.
    Garnero P, Ayral X, Rousseau JC et al (2002) Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis. Arthritis Rheum 46(10):2613–2624PubMedCrossRefGoogle Scholar
  18. 18.
    Valdes AM, Hart DJ, Jones KA et al (2004) Association study of candidate genes for the prevalence and progression of knee osteoarthritis. Arthritis Rheum 50(8):2497–2507PubMedCrossRefGoogle Scholar
  19. 19.
    Kamarainen OP, Solovieva S, Vehmas T et al (2008) Common interleukin-6 promoter variants associate with the more severe forms of distal interphalangeal osteoarthritis. Arthritis Res Ther 10(1):R21Google Scholar
  20. 20.
    Attur M, Wang HY, Kraus VB, et al (2010) Radiographic severity of knee osteoarthritis is conditional on interleukin 1 receptor antagonist gene variations. Ann Rheum Dis 69(5):856–861Google Scholar
  21. 21.
    Altman R, Asch E, Bloch D et al (1986) Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 29(8):1039–1049PubMedCrossRefGoogle Scholar
  22. 22.
    Zhang W, McWilliams DF, Ingham SL et al (2011) Nottingham knee osteoarthritis risk prediction models. Ann Rheum Dis 70(9):1599–1604PubMedCrossRefGoogle Scholar
  23. 23.
    Vilím V, Olejárová M, Machácek S, Gatterová J, Kraus VB, Pavelka K (2002) Serum levels of cartilage oligomeric matrix protein (COMP) correlate with radiographic progression of knee osteoarthritis. Osteoarthritis Cartilage 10(9):707–713PubMedCrossRefGoogle Scholar
  24. 24.
    Botha-Scheepers S, Riyazi N, Watt I et al (2009) Progression of hand osteoarthritis over 2 years: a clinical and radiological follow-up study. Ann Rheum Dis 68(8):1260–1264PubMedCrossRefGoogle Scholar
  25. 25.
    Martínez-Redondo D, Marcuello A, Casajús JA et al (2010) Human mitochondrial haplogroup H: the highest VO2max consumer—is it a paradox? Mitochondrion 10(2):102–107PubMedCrossRefGoogle Scholar
  26. 26.
    Gómez-Durán A, Pacheu-Grau D, López-Gallardo E et al (2010) Unmasking the causes of multifactorial disorders: OXPHOS differences between mitochondrial haplogroups. Hum Mol Genet 19(17):3343–3353PubMedCrossRefGoogle Scholar
  27. 27.
    Mishmar D, Ruiz-Pesini E, Golik P et al (2003) Natural selection shaped regional mtDNA variation in humans. Proc Natl Acad Sci USA 100(1):171–176Google Scholar
  28. 28.
    Kenney MC, Chwa M, Atilano SR et al (2013) Mitochondrial DNA variants mediate energy production and expression levels for CFH, C3 and EFEMP1 genes: implications for age-related macular degeneration. PLoS One 8(1):e54339PubMedCentralPubMedCrossRefGoogle Scholar
  29. 29.
    Ruiz-Pesini E, Lapeña AC, Díez-Sánchez C et al (2000) Human mtDNA haplogroups associated with high or reduced spermatozoa motility. Am J Hum Genet 67(3):682–696PubMedCentralPubMedCrossRefGoogle Scholar
  30. 30.
    Larsen S, Díez-Sánchez C, Rabøl R, Ara I, Dela F, Helge JW (2014) Increased intrinsic mitochondrial function in humans with mitochondrial haplogroup H. Biochim Biophys Acta 1837(2):226–231PubMedCrossRefGoogle Scholar
  31. 31.
    Ruiz-Pesini E, Mishmar D, Brandon M, Procaccio V, Wallace DC (2004) Effects of purifying and adaptive selection on regional variation in human mtDNA. Science 303(5655):223–226PubMedCrossRefGoogle Scholar
  32. 32.
    Wallace DC (1999) Mitochondrial diseases in man and mouse. Science 283(5407):1482–1488PubMedCrossRefGoogle Scholar
  33. 33.
    Mueller EE, Brunner SM, Mayr JA, Stanger O, Sperl W, Kofler B (2012) Functional differences between mitochondrial haplogroup T and haplogroup H in HEK293 cybrid cells. PLoS One 7(12):e52367PubMedCentralPubMedCrossRefGoogle Scholar
  34. 34.
    Hudson G, Panoutsopoulou K, Wilson I et al (2013) No evidence of an association between mitochondrial DNA variants and osteoarthritis in 7393 cases and 5122 controls. Ann Rheum Dis 72(1):136–139PubMedCentralPubMedCrossRefGoogle Scholar
  35. 35.
    Zeggini E, Panoutsopoulou K, Southam L et al (2012) Identification of new susceptibility loci for osteoarthritis (arcOGEN): a genome-wide association study. Lancet 380(9844):815–823PubMedCrossRefGoogle Scholar
  36. 36.
    Zhai G, Hart DJ, Kato BS, MacGregor A, Spector TD (2007) Genetic influence on the progression of radiographic knee osteoarthritis: a longitudinal twin study. Osteoarthritis Cartilage 15(2):222–225Google Scholar
  37. 37.
    Kerkhof HJ, Doherty M, Arden NK et al (2011) Large-scale meta-analysis of interleukin-1 beta and interleukin-1 receptor antagonist polymorphisms on risk of radiographic hip and knee osteoarthritis and severity of knee osteoarthritis. Osteoarthritis Cartilage 19(3):265–271Google Scholar
  38. 38.
    Miyamoto Y, Mabuchi A, Shi D et al (2007) A functional polymorphism in the 5′ UTR of GDF5 is associated with susceptibility to osteoarthritis. Nat Genet 39(4):529–533PubMedCrossRefGoogle Scholar
  39. 39.
    Takahashi H, Nakajima M, Ozaki K, Tanaka T, Kamatani N, Ikegawa S (2010) Prediction model for knee osteoarthritis based on genetic and clinical information. Arthritis Res Ther 12(5):R187Google Scholar
  40. 40.
    Valdes AM, Doherty M, Spector TD (2008) The additive effect of individual genes in predicting risk of knee osteoarthritis. Ann Rheum Dis 67(1):124–127Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  • Angel Soto-Hermida
    • 1
  • Mercedes Fernández-Moreno
    • 1
  • Sonia Pértega-Díaz
    • 1
    • 2
  • Natividad Oreiro
    • 1
  • Carlos Fernández-López
    • 1
  • Francisco J. Blanco
    • 1
    • 3
    Email author
  • Ignacio Rego-Pérez
    • 1
    Email author
  1. 1.Grupo de Genómica, Servicio de Reumatología, Instituto de Investigación Biomédica de A Coruña (INIBIC)Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas, Universidade da Coruña (UDC)A Coruña, EspañaSpain
  2. 2.Unidad de Epidemiología, Instituto de Investigacion Biomedica de A Coruña (INIBIC)Complexo Hospitalario Universitario de A Coruña (CHUAC), SergasA CoruñaSpain
  3. 3.CIBER de BioingenieriaBiomateriales y Nanomedicina (CIBER-BBN)ValenciaSpain

Personalised recommendations